Brain metastases

nork Raizer, Jeffrey J., Abrey, Lauren E.
Argitaratua 2007

Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy

nork Raizer, Jeffrey J., Malkin, Mark G., Kleber, Martin, Abrey, Lauren E.
Argitaratua 2004

A phase II study of extended low-dose temozolomide in recurrent malignant gliomas.

nork Khan, Raja B., Raizer, Jeffrey J., Malkin, Mark G., Bazylewicz, Kimberley A., Abrey, Lauren E.
Argitaratua 2002

The Impact of Perioperative Arterial Infarct on Recurrence, Functional Outcomes, and Survival in Glioblastoma Patients

nork Lupa, Jakob T., Raizer, Jeffrey J., Helenowski, Irene B., Liu, Benjamin P., Kesavabhotla, Kartik, Tate, Matthew C.
Argitaratua izan da Front Oncol (2020)

Financial burden experienced by patients undergoing treatment for malignant gliomas

nork Kumthekar, Priya, Stell, Becky V., Jacobs, Daniel I., Helenowski, Irene B., Rademaker, Alfred W., Grimm, Sean A., Bennett, Charles L., Raizer, Jeffrey J.
Argitaratua izan da Neurooncol Pract (2014)

Gene–protein correlation in single cells

nork Renfrow, Jaclyn J., Scheck, Adrienne C., Dhawan, Neil S., Lukac, Paul J., Vogel, Hannes, Chandler, James P., Raizer, Jeffrey J., Harsh, Griffith R., Chakravarti, Arnab, Bredel, Markus
Argitaratua 2011

A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma

nork Wen, Patrick Y., Schiff, David, Cloughesy, Timothy F., Raizer, Jeffrey J., Laterra, John, Smitt, Melanie, Wolf, Michael, Oliner, Kelly S., Anderson, Abraham, Zhu, Min, Loh, Elwyn, Reardon, David A.
Argitaratua 2011

Survey of treatment recommendations for anaplastic oligodendroglioma

nork Abrey, Lauren E., Louis, David N., Paleologos, Nina, Lassman, Andrew B., Raizer, Jeffrey J., Mason, Warren, Finlay, Jonathan, MacDonald, David R., DeAngelis, Lisa M., Cairncross, J. Gregory
Argitaratua 2007

Brain and leptomeningeal metastases from cutaneous melanoma: Survival outcomes based on clinical features

nork Raizer, Jeffrey J., Hwu, Wen-Jen, Panageas, Katherine S., Wilton, Andrew, Baldwin, Drew E., Bailey, Elizabeth, von Althann, Caroline, Lamb, Lynne A., Alvarado, Gladys, Bilsky, Mark H., Gutin, Philip H.
Argitaratua 2008

Improving vaccine efficacy against malignant glioma

nork Ladomersky, Erik, Genet, Matthew, Zhai, Lijie, Gritsina, Galina, Lauing, Kristen L., Lulla, Rishi R., Fangusaro, Jason, Lenzen, Alicia, Kumthekar, Priya, Raizer, Jeffrey J., Binder, David C., James, C. David, Wainwright, Derek A.
Argitaratua izan da Oncoimmunology (2016)

Concordance of patient and caregiver reports in evaluating quality of life in patients with malignant gliomas and an assessment of caregiver burden

nork Jacobs, Daniel I., Kumthekar, Priya, Stell, Becky V., Grimm, Sean A., Rademaker, Alfred W., Rice, Laurie, Chandler, James P., Muro, Kenji, Marymont, MaryAnne, Helenowski, Irene B., Wagner, Lynne I., Raizer, Jeffrey J.
Argitaratua izan da Neurooncol Pract (2014)

The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy

nork Zhai, Lijie, Dey, Mahua, Lauing, Kristen L., Gritsina, Galina, Kaur, Rajwant, Lukas, Rimas V., Nicholas, M. Kelly, Rademaker, Alfred W., Dostal, Carlos R., McCusker, Robert H., Raizer, Jeffrey J., Parsa, Andrew T., Bloch, Orin, Wainwright, Derek A.
Argitaratua izan da J Clin Neurosci (2015)

NT113, a pan-ERBB Inhibitor with High Brain Penetrance, Inhibits the Growth of Glioblastoma Xenografts with EGFR Amplification

nork Yoshida, Yasuyuki, Ozawa, Tomoko, Yao, Tsun-Wen, Shen, Wang, Brown, Dennis, Parsa, Andrew T., Raizer, Jeffrey J., Cheng, Shi-Yuan, Stegh, Alexander H., Mazar, Andrew P., Giles, Francis J., Sarkaria, Jann N., Butowski, Nicholas, Nicolaides, Theodore, James, C. David
Argitaratua izan da Mol Cancer Ther (2014)

Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final...

nork Morris, Patrick G., Correa, Denise D., Yahalom, Joachim, Raizer, Jeffrey J., Schiff, David, Grant, Barbara, Grimm, Sean, Lai, Rose K., Reiner, Anne S., Panageas, Kathy, Karimi, Sasan, Curry, Richard, Shah, Gaurav, Abrey, Lauren E., DeAngelis, Lisa M., Omuro, Antonio
Argitaratua izan da J Clin Oncol (2013)

Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas

nork Drumm, Michael R, Dixit, Karan S, Grimm, Sean, Kumthekar, Priya, Lukas, Rimas V, Raizer, Jeffrey J, Stupp, Roger, Chheda, Milan G, Kam, Kwok-Ling, McCord, Matthew, Sachdev, Sean, Kruser, Timothy, Steffens, Alicia, Javier, Rodrigo, McCortney, Kathleen, Horbinski, Craig
Argitaratua izan da Neuro Oncol (2020)

Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression

nork Huang, Raymond Y, Unadkat, Prashin, Bi, Wenya Linda, George, Elizabeth, Preusser, Matthias, McCracken, Jay D, Keen, Joseph R, Read, William L, Olson, Jeffrey J, Seystahl, Katharina, Le Rhun, Emilie, Roelcke, Ulrich, Koeppen, Susanne, Furtner, Julia, Weller, Michael, Raizer, Jeffrey J, Schiff, David, Wen, Patrick Y
Argitaratua izan da Neuro Oncol (2019)

Economics of Malignant Gliomas: A Critical Review

nork Raizer, Jeffrey J., Fitzner, Karen A., Jacobs, Daniel I., Bennett, Charles L., Liebling, Dustin B., Luu, Thanh Ha, Trifilio, Steven M., Grimm, Sean A., Fisher, Matthew J., Haleem, Meraaj S., Ray, Paul S., McKoy, Judith M., DeBoer, Rebecca, Tulas, Katrina-Marie E., Deeb, Mohammed, McKoy, June M.
Argitaratua izan da J Oncol Pract (2015)

ATCT-22 NRG ONCOLOGY/RTOG 1122: PHASE II DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB WITH OR WITHOUT AMG 386 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR GLIOSARCOMA

nork Lee, Eudocia Q., Zhang, Peixin, Wen, Patrick Y., Gerstner, Elizabeth R., Reardon, David A., Aldape, Ken, de Groot, John F., Choe, Kevin S., Raizer, Jeffrey J., Kim, Lyndon J., Chmura, Steven J., Robins, H. Ian, Connelly, Jennifer, Battiste, James, Villano, John, Wagle, Naveed, Merrell, Ryan T., Wendland, Merideth, Mehta, Minesh P.
Argitaratua izan da Neuro Oncol (2015)

Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma

nork Lee, Eudocia Q., Reardon, David A., Schiff, David, Drappatz, Jan, Muzikansky, Alona, Grimm, Sean A., Norden, Andrew D., Nayak, Lakshmi, Beroukhim, Rameen, Rinne, Mikael L., Chi, Andrew S., Batchelor, Tracy T., Hempfling, Kelly, McCluskey, Christine, Smith, Katrina H., Gaffey, Sarah C., Wrigley, Brendan, Ligon, Keith L., Raizer, Jeffrey J., Wen, Patrick Y.
Argitaratua izan da Neuro Oncol (2015)

A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy(†)

nork Raizer, Jeffrey J., Abrey, Lauren E., Lassman, Andrew B., Chang, Susan M., Lamborn, Kathleen R., Kuhn, John G., Yung, W.K. Alfred, Gilbert, Mark R., Aldape, Kenneth A., Wen, Patrick Y., Fine, Howard A., Mehta, Minesh, DeAngelis, Lisa M., Lieberman, Frank, Cloughesy, Timothy F., Robins, H. Ian, Dancey, Janet, Prados, Michael D.
Argitaratua 2010